In a retrospective analysis of 60 primary NB specimens, increased levels of MRP1 expression were strongly associated with reduced overall survival and event-free survival and they were found to predict outcome also in patients with MYCN non-amplified tumors [44]. This evidence concerns the gene MYCN and neuroblastoma.